Showing results (41-50 of 163) with videos related to

Sort By:
Pageof 17
Cancer Research|December 25, 2002
Activity of the Bcr-Abl kinase inhibitor PD180970 against clinically relevant Bcr-Abl isoforms that cause resistance to imatinib mesylate (Gleevec, STI571)Paul La Rosée, Amie S Corbin, Eric P Stoffregen, et al.
Blood|February 11, 2003
Several Bcr-Abl kinase domain mutants associated with imatinib mesylate resistance remain sensitive to imatinibAmie S Corbin, Paul La Rosée, Eric P Stoffregen, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 5, 2021
Anticoagulation management post-transjugular intrahepatic portosystemic shunt in portal hypertension associated with myeloproliferative neoplasmsMouhamed Yazan Abou-Ismail, Josef T Prchal, Michael W Deininger, et al.
Biochemical Pharmacology|March 9, 2010
Sequential treatment with flavopiridol synergistically enhances pyrrolo-1,5-benzoxazepine-induced apoptosis in human chronic myeloid leukaemia cells including those resistant to imatinib treatmentSandra A Bright, Giuseppe Campiani, Michael W Deininger, et al.
Cancer Research|February 11, 1998
Selective induction of leukemia-associated fusion genes by high-dose ionizing radiationM W Deininger, S Bose, J Gora-Tybor, et al.
The Journal of Allergy and Clinical Immunology. in Practice|November 4, 2025
KIT-Targeting Drugs in the Management of Nonadvanced and Advanced Systemic MastocytosisAndreas Reiter, Julien Rossignol, Michael W Deininger, et al.
Blood|July 27, 2000
Selection and characterization of BCR-ABL positive cell lines with differential sensitivity to the tyrosine kinase inhibitor STI571: diverse mechanisms of resistanceF X Mahon, M W Deininger, B Schultheis, et al.
Genes, Chromosomes & Cancer|December 18, 2001
Transcription factor BACH2 is transcriptionally regulated by the BCR/ABL oncogeneS A Vieira, M W Deininger, A Sorour, et al.
Blood Reviews|May 15, 2022
Long-term safety review of tyrosine kinase inhibitors in chronic myeloid leukemia - What to look for when treatment-free remission is not an optionJeffrey H Lipton, Tim H Brümmendorf, Carlo Gambacorti-Passerini, et al.
Blood|August 27, 2009
Acute dasatinib exposure commits Bcr-Abl-dependent cells to apoptosisJennifer L Snead, Thomas O'Hare, Lauren T Adrian, et al.
Pageof 17